SCHEMBL4520702

SCHEMBL4520702

CS(=O)(=O)NCCc1ccccc1

nearest known ligand 0.79

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.79
L3MBTL1 Q9Y468 1/20 0.56
TAAR1 Q96RJ0 2/20 0.54
HSD17B10 Q99714 1/20 0.54
PRMT1 Q99873 1/20 0.54
NQO2 P16083 1/20 0.54
ALDH1A1 P00352 3/20 0.54
CA12 O43570 1/20 0.54
CA7 P43166 1/20 0.54
CA9 Q16790 1/20 0.54
CA14 Q9ULX7 1/20 0.54
ATM Q13315 1/20 0.54
KDM4E B2RXH2 1/20 0.53
LMNA P02545 1/20 0.53
CYP3A4 P08684 1/20 0.53
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
BLM P54132 1/20 0.53
GFER P55789 1/20 0.53
PMP22 Q01453 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27426082 0.94 POLB (0.71) POLBL3MBTL1TAAR1HSD17B10PRMT1
SCHEMBL5994696 0.93 POLB (0.69) POLBL3MBTL1TAAR1HSD17B10PRMT1
SCHEMBL10312250 0.89 POLB (0.64) POLBL3MBTL1NQO2ALDH1A1CA12
SCHEMBL4513715 0.88 POLB (1.00) POLBL3MBTL1ALDH1A1GAAMEN1
SCHEMBL15218452 0.86 POLB (0.89) POLBL3MBTL1ALDH1A1KDM4ECYP3A4
SCHEMBL5991959 0.83 GRIA4 (0.63) POLBL3MBTL1NQO2ALDH1A1CA12
SCHEMBL15672851 0.83 MEN1 (0.58) POLBL3MBTL1TAAR1HSD17B10PRMT1
SCHEMBL14719879 0.82 MEN1 (0.77) POLBL3MBTL1TAAR1HSD17B10PRMT1
SCHEMBL660035 0.82 ALDH1A1 (0.68) POLBL3MBTL1ALDH1A1CA12CA9
SCHEMBL4887431 0.80 CA1 (0.58) POLBPRMT1NQO2ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025132825-A1 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) 2025-06-26 WO claimed
US-7560460-B2 Substituted piperazines and methods of use AMGEN INC. (US) 2009-07-14 US claimed
EP-1417190-B1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC (US) 2008-10-22 EP claimed
EP-1416933-B8 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC (US) 2008-08-27 EP claimed
EP-1416933-B1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM INC (US) 2008-01-02 EP claimed
US-20070265248-A1 Substituted piperazines and methods of use AMGEN INC. (US) 2007-11-15 US claimed
US-7115607-B2 Substituted piperazinyl amides and methods of use AMGEN INC. (US) 2006-10-03 US claimed
US-6977264-B2 Substituted piperidines and methods of use AMGEN INC. (US) 2005-12-20 US claimed
EP-1416933-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgem, Inc. (US) 2004-05-12 EP claimed
EP-1417190-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR Amgen Inc. (US) 2004-05-12 EP claimed
US-20040006067-A1 Substituted piperidines and methods of use AMGEN INC. 2004-01-08 US claimed
US-20030220324-A1 Substituted piperazines and methods of use AMGEN INC. 2003-11-27 US claimed
WO-2003009847-A1 SUBSTITUTED PIPERIDINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEM, INC. (US) 2003-02-06 WO claimed
WO-2003009850-A1 SUBSTITUTED PIPERAZINES AS MODULATORS OF THE MELANOCORTIN RECEPTOR AMGEN INC. (US) 2003-02-06 WO claimed
WO-2025132825-A1 1H-IMIDAZO[4,5-C]QUINOLINE METAL-BASED COMPLEXES USEFUL AS MEDICAMENTS FUNDACIÓN DONOSTIA INTERNATIONAL PHYSICS CENTER - DIPC (ES) 2025-06-26 WO disclosed
EP-3838903-A1 PYRROLO[2,3-D]PYRIMIDINE DERIVATIVE AS JANUS KINASE INHIBITOR Incyte Holdings Corporation (US) 2021-06-23 EP disclosed
US-10383880-B2 Carbazole-containing sulfonamides as cryptochrome modulators Synchronicity (US) 2019-08-20 US disclosed
US-5753652-A Antiretroviral hydrazine derivatives NOVARTIS CORPORATION (US) 1998-05-19 US disclosed
CN-1156141-A Phenethylamine derivative with cardiovascular activity UNIV CHINA PHARMACY (CN) 1997-08-06 CN disclosed
US-4863905-A PEPTIDES WARNER-LAMBERT COMPANY (US) 1989-09-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030220324-A1 Substituted piperazines and methods of use MC5R, MC4R, MC1R POLB 2338/4885L3MBTL1 3378/4885TAAR1 185/4885
US-20070265248-A1 Substituted piperazines and methods of use MC5R, MC4R, MC1R POLB 2338/4885L3MBTL1 3378/4885TAAR1 185/4885
US-10383880-B2 Carbazole-containing sulfonamides as cryptochrome modulators CRY1, CRY2, CRYAB POLB 4394/4885L3MBTL1 4425/4885TAAR1 2225/4885
US-20040006067-A1 Substituted piperidines and methods of use MC4R, MC5R, MC1R POLB 1584/4885L3MBTL1 3514/4885TAAR1 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.